Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-23-032707

Chief Executive Officer sold 57,755 shares at an average $28.12 ($1,624,223)

  • Chief Executive Officer acquired 57,755 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2023-09-18 Option exercise +57,755 $4.75 $274,336 3,819,093 D
Anzalone Christopher Richard Chief Executive Officer 2023-09-18 Sale −31,523 $28.00 $882,644 3,787,570 D
Anzalone Christopher Richard Chief Executive Officer 2023-09-18 Sale −26,232 $28.27 $741,579 3,761,338 D
Derivatives
Anzalone Christopher Richard Chief Executive Officer 2023-09-18 Option exercise · Stock Option (right to buy) +57,555 409,225 D
Open-market sales · 57,755 sh · avg $28.12 · $1,624,223
Loading xslF345X05/wf-form4_169524780099268.xml…